Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV

Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA. 2012;308(4):370-378.

Publication Type:

Journal Article

Authors:

Limketkai, B.N.; S H Mehta; Sutcliffe, C.G.; Higgins, Y.M.; Torbenson, M.S.; Brinkley, S.C.; Moore, R.D.; Thomas, D.L.; M S Sulkowski

Source:

JAMA, Volume 308, Issue 4, p.370-378 (2012)

Keywords:

Adult, Antiretroviral, Antiretroviral Therapy, Antiviral Agents, Baltimore, Biopsy, Carcinoma, Carcinoma,Hepatocellular, classification, coinfection, complications, CONTEXT, Disease, Disease Progression, drug therapy, End Stage Liver Disease, epidemiology, Female, Fibrosis, HCV, hepatitis, Hepatitis C, hepatitis C virus, Hiv, HIV Infections, Human, Humans, Incidence, Liver, Liver Cirrhosis, Liver Neoplasms, Male, Maryland, Medicine, Middle Aged, Mortality, nonresponder, pathology, Patients, Prospective Studies, Research, Research Support, Risk, sustained virologic response, therapeutic use, therapy, Treatment Outcome

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/22820790

Export Citation:

RIS Format

Top